Speaker illustration

Doctor Roni Nielsen

Aarhus University Hospital, Aarhus (Denmark)

Member of:

European Society of Cardiology
EAPCI

Cardiovascular and metabolic effects of treatment with the ketone body 3-hydroxybutyrate in patients with chronic heart failure.

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Basic Science

Session: Metabolic Dysfunction in Heart Failure: Can We Harness the Power of Ketones?

Thumbnail

The effect of liraglutide on natriuretic peptides and copeptin in heart failure patients

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session: Rapid Fire 2 - Biomarker: present and future

Thumbnail

The ketone body 3-hydroxybutyrate increases cardiac output without affecting myocardial external efficiency

Event: ESC Congress 2018

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session: Skeletal muscle and energy metabolism: do they matter in heart failure?

Thumbnail

The ketone body 3-hydroxybutyrate increases cardiac output and left ventricular contractile function in heart failure patients with reduced ejection fraction

Event: Heart Failure 2018 & World Congress on Acute Heart Failure

Topic: Treatment, Other

Session: Patient management - From oral treatment to transplant

Thumbnail

Quantitative estimation of extravascular lung water volume and preload by dynamic 15O-H2O positron emission tomography

Event: Heart Failure 2018 & World Congress on Acute Heart Failure

Topic: Haemodynamics of Heart Failure

Session: Chronic Heart Failure – Pathophysiology and Mechanisms

Thumbnail

Effect of liraglutide on myocardial glucose uptake and blood flow in non-diabetic heart failure patients

Event: HEART FAILURE 2016

Topic: Metabolism / Diabetes mellitus

Session: Metabolism / Diabetes mellitus / Obesity

Thumbnail

This platform is supported by

logo Novo Nordisk